Haleon plc

HLN· NYSE· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$9.80-0.66%

2026-08-03

Financials

Valuation Metrics

Haleon plc's Market Cap is $43.43B. At end of 2025 it was $42.32B. Ranked #359 of 3,112 in US market (top 12%), #257 of 1,667 on NYSE (top 15%), #18 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 7%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$43.43B	US#359/3,112 Sec#18/269
Revenue	$25.46B	US#259/3,112 Sec#15/269
Net Income	$3.67B	US#193/3,112 Sec#15/269
Total Assets	$43.83B	US#363/3,112 Sec#15/269
Net Assets	$22.06B	US#227/3,112 Sec#15/269
Value
P/E	11.82x	US#377/3,112 Sec#16/269
P/B	1.97x	US#1,165/3,112 Sec#52/269
PEG	0.15x	US#259/3,112 Sec#11/269
P/S	1.71x	US#1,092/3,112 Sec#23/269
EV/EBITDA	8.47x	US#546/3,112 Sec#21/269
Profitability
ROE	16.65%	US#757/3,112 Sec#42/269
ROA	8.38%	US#581/3,112 Sec#40/269
Op. Margin	21.32%	US#837/3,112 Sec#40/269
Revenue Growth	98.41%	US#149/3,112 Sec#32/269
Earnings Growth	76.43%	US#432/3,112 Sec#18/269
Financial Health
Debt Ratio	98.30%	US#1,069/3,112 Sec#168/269
Total Debt	$11.56B	US#360/3,112 Sec#17/269
Cash	$1.78B	US#460/3,112 Sec#25/269
Current Ratio	0.92x	US#2,366/3,112 Sec#263/269
Net Debt/EBITDA	1.56x	US#1,222/3,112 Sec#56/269
Dividend
Div. Yield	1.90%	US#951/3,112 Sec#17/269
Div. Growth	5.02%	US#809/3,112 Sec#11/269
Performance
1Y Return	1.50%	US#1,969/3,112 Sec#189/269
1M Return	-0.15%	US#1,675/3,112 Sec#77/269
From 52W High	-13.08%	US#1,281/3,112 Sec#76/269
1Y MDD	-23.58%	US#929/3,112 Sec#48/269
Trading
Volume	12,619,510 shares	US#124/3,112 Sec#9/269
Trading Value	$125M	US#776/3,112 Sec#45/269
Per Share
EPS	$0.81	US#1,700/3,112 Sec#56/269
BPS	$4.76	US#2,245/3,112 Sec#134/269